Crosspoint Capital Strategies’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Crosspoint Capital Strategies’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-78	Closed	-$8K	–	678
2015 Q1	$8K	Buy	+78	New	+$5.2K	﹤0.01%	407

Crosspoint Capital Strategies's ASPX Position: Q2 2015 in Review

Crosspoint Capital Strategies sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 78 shares — an estimated $8K sold.

Crosspoint Capital Strategies first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $8K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Crosspoint Capital Strategies reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Crosspoint Capital Strategies sold 78 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $8K.
Crosspoint Capital Strategies first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Crosspoint Capital Strategies's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $8K in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2015, filed 24 Aug 2015.